LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

McKesson Corp

Затворен

СекторЗдравеопазване

981.54 1.07

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

972.54

Максимум

986.33

Ключови измерители

By Trading Economics

Приходи

40M

1.3B

Продажби

3B

106B

P/E

Средно за сектора

27.395

108.767

Дивидентна доходност

0.32

Марж на печалбата

1.177

Служители

43,000

EBITDA

374M

1.8B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+1.61% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.32%

2.21%

Следващи печалби

7.05.2026 г.

Следваща дата на дивидент

1.04.2026 г.

Следваща дата на екс-дивидент

2.03.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

12B

117B

Предишно отваряне

980.47

Предишно затваряне

981.54

Настроения в новините

By Acuity

46%

54%

158 / 352 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

26.02.2026 г., 22:04 ч. UTC

Печалби

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

26.02.2026 г., 23:55 ч. UTC

Пазарно говорене

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

26.02.2026 г., 23:40 ч. UTC

Придобивния, сливания и поглъщания

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- Update

26.02.2026 г., 23:37 ч. UTC

Пазарно говорене

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

26.02.2026 г., 23:32 ч. UTC

Печалби

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

26.02.2026 г., 23:19 ч. UTC

Придобивния, сливания и поглъщания

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26.02.2026 г., 23:18 ч. UTC

Придобивния, сливания и поглъщания

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26.02.2026 г., 23:12 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Global Equities Roundup: Market Talk

26.02.2026 г., 23:12 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Netflix Gives Up in Bidding War Over Warner -- Market Talk

26.02.2026 г., 23:01 ч. UTC

Придобивния, сливания и поглъщания

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26.02.2026 г., 23:00 ч. UTC

Придобивния, сливания и поглъщания

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26.02.2026 г., 23:00 ч. UTC

Придобивния, сливания и поглъщания

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26.02.2026 г., 22:55 ч. UTC

Придобивния, сливания и поглъщания

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26.02.2026 г., 22:43 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

26.02.2026 г., 22:43 ч. UTC

Пазарно говорене

RBA Hike In March Is Being Underpriced -- Market Talk

26.02.2026 г., 22:33 ч. UTC

Придобивния, сливания и поглъщания

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26.02.2026 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26.02.2026 г., 22:13 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Bidding War Over Warner Bros. Set to Continue -- Market Talk

26.02.2026 г., 21:59 ч. UTC

Печалби

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

26.02.2026 г., 21:58 ч. UTC

Придобивния, сливания и поглъщания

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

26.02.2026 г., 21:49 ч. UTC

Печалби

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

26.02.2026 г., 21:45 ч. UTC

Печалби

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

26.02.2026 г., 21:44 ч. UTC

Печалби

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

26.02.2026 г., 21:44 ч. UTC

Печалби

Coles Expects Market to Remain Highly Competitive

26.02.2026 г., 21:44 ч. UTC

Печалби

Coles Says Supermarket Customers Remain Value Oriented

26.02.2026 г., 21:43 ч. UTC

Печалби

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

26.02.2026 г., 21:43 ч. UTC

Печалби

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

26.02.2026 г., 21:42 ч. UTC

Придобивния, сливания и поглъщания

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

26.02.2026 г., 21:41 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

1.61% нагоре

12-месечна прогноза

Среден 990.1 USD  1.61%

Висок 1,107 USD

Нисък 885 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

11 ratings

9

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

No Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

158 / 352 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat